Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway

Xuefeng Shi(Ningbo No. 2 Hospital), Ting Cai(McGill University)
Scientific Reports
August 3, 2023
Cited by 9


Related Papers